The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract ...

Abrysvo can prevent lower respiratory tract disease caused by RSV for people between the ages of 18 and 59 who are at ...

Respiratory virus season has arrived, and hopefully you’re up to date on vaccinations that can help prevent infectious ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO® (Respiratory ...

Free shots that can protect babies from respiratory syncytial virus are being offered by some health-care providers in ...

Pfizer (PFE) announced that the U.S. FDA has approved Abrysvo, the company’s bivalent RSV prefusion F vaccine, for the prevention of ...

There is also a vaccine called Abrysvo under the brand name and RSVpreF under the generic name, for pregnant women between 32 ...

Tuesday's approval makes Abrysvo the first RSV vaccine indicated for adults younger than 50, the biopharmaceutical company said. Last year, it was approved for use by those 60 years and older, as well ...

Clesrovimab, formerly known as MK-1654, is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody.

On Tuesday, CDC Director Dr. Mandy Cohen rolled up her sleeves to get the updated COVID-19 vaccine at the CDC’s employee ...

A Sherwood Forest Hospitals employee’s child almost died from the RSV virus at just one week old. Now, she wants to highlight ...

You'd hardly know it with the recent streak of summer weather, but we're weeks away from colder days when respiratory viruses ...